US Stock MarketDetailed Quotes

Takeda Pharmaceutical (TAK)

Watchlist
  • 16.620
  • -0.060-0.36%
Close May 1 16:00 ET
  • 16.620
  • 0.0000.00%
Post 20:01 ET
52.51BMarket Cap73.54P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Takeda Pharmaceutical (TAK) Revenue Breakdown Overview

By Business/Source

Currency:JPY
2026/Q1
Stock NameRevenueRatio
Research, development, manufacturing, marketing and out-licensing of pharmaceutical products1.11T100.00%

By Country/Region

Currency:JPY
2025/FY
Stock NameRevenueRatio
United States (US)2.38T51.94%
Europe and Canada1.06T23.03%
Japan418.46B9.13%
Latin America235.85B5.15%
China191.74B4.19%
Other128.85B2.81%
Asia (excluding Japan & China)99.39B2.17%
Russia/Commonwealth of Independent States (CIS)72.36B1.58%
View all
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -